4587.T Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 geg. 2024 @ 09:15):

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics...

Stats
Dzisiejszy wolumen	1.31M
Średni wolumen	932 185
Kapitalizacja rynkowa	251.37B
EPS	¥0 ( 2024-02-14 )
Następna data zysków	( ¥10.93 ) 2024-05-08
Last Dividend	¥0 ( N/A )
Next Dividend	¥0 ( N/A )
P/E	83.10
ATR14	¥1.756 (0.09%)

Wolumen Korelacja

Długi: -0.16 (neutral)

Krótki: 0.83 (strong)

Signal:(48.44) Same movement expected

PeptiDream Inc. Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PeptiDream Inc. Korelacja - Waluta/Towar

0.82
( strong )

0.78
( moderate )

0.81
( strong )

0.78
( moderate )

-0.48
( neutral )

-0.83
( strong negative )

PeptiDream Inc. Finanse

Annual	2023
Przychody:	¥28.71B
Zysk brutto:	¥16.86B (58.73 %)
EPS:	¥23.41

FY	2023
Przychody:	¥28.71B
Zysk brutto:	¥16.86B (58.73 %)
EPS:	¥23.41

FY	2022
Przychody:	¥26.85B
Zysk brutto:	¥18.11B (67.46 %)
EPS:	¥58.19

FY	2021
Przychody:	¥9.37B
Zysk brutto:	¥7.01B (74.82 %)
EPS:	¥28.70

Financial Reports:

No articles found.

PeptiDream Inc.

PeptiDream Inc., a biopharmaceutical company, engages in the discovery and development of constrained peptides, small molecules, and peptide-drug conjugate therapeutics. The company develops its products based on its Peptide Discovery Platform System, a drug finding platform for the development of peptides. It has a collaborative research and exclusive license agreement with Takeda Pharmaceutical Company Limited to develop peptide drug conjugates for neuromuscular diseases. The company was incorporated in 2006 and is headquartered in Kawasaki, Japan.

Aktualne aktualizacje dla PeptiDream Inc. [4587.T]

Upcoming Earnings Alert